January 16, 2018
Rose
Owkin, a predictive analytics company that aims to accelerates drug discovery and development, just landed $11 million in Series A funding. The round was led by Otium Venture with participation from Cathay Innovation, Plug and Play, and NJF Capital. This announcement brings the company’s total funding to $13.1 million.
from MobiHealthNews http://ift.tt/2DgXQIJ
January 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Fitbit Ace, a fitness wearable for kids, goes on sale for $99.95- Biological tissue sensor startup Sensome rakes in $5.4M in funding
- Glooko launches diabetes analytics platform
- A third patent filing shows blood pressure monitoring on Apple's radar
- Roche launches CoaguChek Vantus to monitor coagulation levels wirelessly
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment